Roche broadens cervical cancer offering with €190m mtm buy
This article was originally published in Clinica
Executive Summary
Roche Diagnostics is consolidating its presence in the cervical cancer testing market with the agreed acquisition of mtm laboratories, a privately-held German firm specialising in tests to detect precancerous cervical lesions.